drugset / Trial / NCT04796714

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

NCT04796714 ↗

Phase 4 Recruiting 60 enrolled University Hospital, Bordeaux
RandomizedParallel-groupOpen-labelTreatment

Summary

The APPENDAGE study is a phase 4 multicentre randomized opened clinical trial comparing 2 different antithrombotic strategies following left atrial appendage closure (LAAC) in patients with non valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on cerebrovascular magnetic resonance imaging (MRI) studies.

Timeline

Start
2022-10-03
Primary completion
2027-05-03
Completion
2027-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg —
Background Aspirin Small molecule 160 mg —